AgomAb Therapeutics NV: CFO Kemula Pierre Thadee Victor bought 10,000 shares

What happened
Kemula Pierre Thadee Victor, chief financial officer, purchased a total of 10,000 common shares on Oct 6, 2026: 3,000 shares at $8.67 for $26,010; 5,000 shares at $8.57 for $42,850; and 2,000 shares at $8.54 for $17,080. The combined value reported is $85,940.

Key details

• Transaction date: Oct 6, 2026. Prices and values: 3,000 @ $8.67 = $26,010; 5,000 @ $8.57 = $42,850; 2,000 @ $8.54 = $17,080.
• Transaction code: P (purchase).
• Filing date: Oct 7, 2026 (Accession 0002119332-26-000001).
• Shares owned after the transaction: not reported in this filing.
• Footnote F1: the common shares may be represented by American Depositary Shares, each of which currently represents one common share.
• Filing timeliness: not indicated as late in the form; filing date was Oct 7, 2026.

Why it may matter
This filing reports open-market purchases by the CFO (transaction code P); it does not report an option exercise, award, or gift. A filing does not show why the insider traded or why the company acted.